Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.46USD
−133.82 MUSD
79.20 MUSD
19.70 M
About Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ENTA is 10.95 USD — it has decreased by −2.62% in the past 24 hours. Watch Enanta Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Enanta Pharmaceuticals, Inc. stocks are traded under the ticker ENTA.
ENTA stock has fallen by −9.88% compared to the previous week, the month change is a 1.67% rise, over the last year Enanta Pharmaceuticals, Inc. has showed a 21.13% increase.
We've gathered analysts' opinions on Enanta Pharmaceuticals, Inc. future price: according to them, ENTA price has a max estimate of 30.00 USD and a min estimate of 10.00 USD. Watch ENTA chart and read a more detailed Enanta Pharmaceuticals, Inc. stock forecast: see what analysts think of Enanta Pharmaceuticals, Inc. and suggest that you do with its stocks.
ENTA reached its all-time high on Jul 6, 2018 with the price of 127.77 USD, and its all-time low was 8.08 USD and was reached on Nov 10, 2023. View more price dynamics on ENTA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ENTA stock is 4.21% volatile and has beta coefficient of 1.30. Track Enanta Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Enanta Pharmaceuticals, Inc. there?
Today Enanta Pharmaceuticals, Inc. has the market capitalization of 238.27 M, it has decreased by −5.43% over the last week.
Yes, you can track Enanta Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Enanta Pharmaceuticals, Inc. is going to release the next earnings report on Nov 25, 2024. Keep track of upcoming events with our Earnings Calendar.
ENTA earnings for the last quarter are −1.07 USD per share, whereas the estimation was −1.43 USD resulting in a 25.31% surprise. The estimated earnings for the next quarter are −1.16 USD per share. See more details about Enanta Pharmaceuticals, Inc. earnings.
Enanta Pharmaceuticals, Inc. revenue for the last quarter amounts to 17.97 M USD, despite the estimated figure of 17.44 M USD. In the next quarter, revenue is expected to reach 17.99 M USD.
ENTA net income for the last quarter is −22.66 M USD, while the quarter before that showed −31.16 M USD of net income which accounts for 27.28% change. Track more Enanta Pharmaceuticals, Inc. financial stats to get the full picture.
No, ENTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 2, 2024, the company has 145.00 employees. See our rating of the largest employees — is Enanta Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Enanta Pharmaceuticals, Inc. EBITDA is −120.34 M USD, and current EBITDA margin is −170.24%. See more stats in Enanta Pharmaceuticals, Inc. financial statements.
Like other stocks, ENTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enanta Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enanta Pharmaceuticals, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enanta Pharmaceuticals, Inc. stock shows the sell signal. See more of Enanta Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.